TOWNSON SHARON (Chief Technology Officer) sold 4.2% of their position (3K shares) of MONTE ROSA THERAPEUTICS, INC. on the open market
Open‑market sale worth $57.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/18/2026ACC: 0001193125-26-275805
Officer· Chief Technology Officer
Since Jun 2021
-3K
Net shares
Net seller
$57.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3K acquired · 6K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3K
Price / share
$6.14
Trade value
$18.42K
% of position
4.4%
6/17/2026
67.84K→70.84K
Common Stock
Direct
Shares
−3K
Price / share
$19.00
Trade value
$57K
% of position
4.2%
6/17/2026
70.84K→67.84K
Total
Net shares
+0.00
Net value
-$38.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2026 | M · Option Exercise | +3K | $6.14 | $18.42K | 4.4% | 67.84K | 70.84K |
| Common Stock Direct | 6/17/2026 | S · Sale | −3K | $19.00 | $57K | 4.2% | 70.84K | 67.84K |
| Total | +0.00 | -$38.58K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3K shares
Shares
−3K
Strike price
6.14
Held after
206.29K
Exercisable
—
6/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3K shares | 6/17/2026 | M · Option Exercise | −3K | 6.14 | — | 206.29K |